다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Free radical biology & medicine, v.29 no.12, 2000년, pp.1199 - 1221
Janero, David R (NitroMed, Inc., Bedford, MA, USA) , Ewing, James F (ArQule, Inc., Woburn, MA, USA)
AI-Helper
AbstractBalloon angioplasty revolutionized interventional cardiology as a nonsurgical procedure to clear a diseased artery of atherosclerotic blockage. Despite its procedural reliability, angioplasty’s long-term outcome can be compromised by restenosis, the recurrence of arterial blockage in ...
Circulation Pearson 97 602 1998 10.1161/01.CIR.97.6.602 Cardiovascular specialty societies and the emerging burden of cardiovascular disease. A call to action
Circulation Grundy 100 988 1999 10.1161/01.CIR.100.9.988 Primary prevention of coronary heart disease. Integrating risk assessment with intervention
N. Engl. J. Med. Gruentzig 301 61 1979 10.1056/NEJM197907123010201 Non-operative dilation of coronary artery stenosis
N. Engl. J. Med. King 331 1044 1994 10.1056/NEJM199410203311602 A randomized trial comparing coronary angioplasty with coronary bypass surgery
Circulation Hollman 68 725 1983 10.1161/01.CIR.68.4.725 Acute occlusion after percutaneous transluminal coronary angioplasty-new approach
N. Engl. J. Med. Ross 295 369 1976 10.1056/NEJM197608122950707 The pathogenesis of atherosclerosis
Fuster 1996 Atherosclerosis and coronary artery disease
Free Radic. Biol. Med. Janero 11 129 1991 10.1016/0891-5849(91)90193-7 Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis
Clin. Cardiol. Vogel 20 426 1997 10.1002/clc.4960200505 Coronary risk factors, endothelial function, and atherosclerosis
Cardiovasc. Drugs Ther. Opie 4 777 1990 10.1007/BF00051275 Myocardial ischemia-metabolic pathways and implications of increased glycolysis
Crit. Rev. Food Sci. Nutr. Janero 35 65 1995 10.1080/10408399509527688 Ischemic heart disease and antioxidants
Janero 411 1994 Natural antioxidants in human health and disease Myocardial ischemia-reperfusion injury and the cardioprotective potential of natural antioxidants
10.1161/01.CIR.100.1.14 Berger, P. B.; Ellis, S. G.; Holmes, D. R.; Granger, C. G.; Criger, D. A.; Betriu, A.; Topol, E. J.; Califf, R. M., for the GUSTO-II investigators. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction. Results from the global use of strategies to open occluded arteries in acute coronary syndromes (GUSTO-IIb) trial. Circulation 100:14-20; 1999.
Circulation Kaiser 72 V-46 1985 CABG 1984
Eur. Heart J. Yusuf 6 556 1985 10.1093/oxfordjournals.eurheartj.a061905 Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction
Circulation White 97 1632 1998 10.1161/01.CIR.97.16.1632 Thrombolysis for acute myocardial infarction
Circulation Ellis 81 IV-43 1990 Interventions in acute myocardial infarction
Am. J. Cardiol. Weintraub 65 183 1990 10.1016/0002-9149(90)90082-C Changing use of coronary angioplasty and coronary bypass surgery in the treatment of chronic coronary artery disease
Ann. Thorac. Surg. Oesterle 66 1045 1998 10.1016/S0003-4975(98)00713-9 Beyond stents
Baim 1986 Cardiac catheterization and angiography Coronary angioplasty
Circulation Kornowski 97 1355 1998 10.1161/01.CIR.97.14.1355 Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions
J. Am. Med. Assoc. Weaver 278 2093 1997 10.1001/jama.278.23.2093 Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction
Prog. Cardiovasc. Dis. Bauters 40 107 1997 10.1016/S0033-0620(97)80003-5 The biology of restenosis
Cardiol. Rev. Casterella 7 219 1999 10.1097/00045415-199907000-00014 Prevention of coronary restenosis
Hum. Pathol. Waller 18 476 1987 10.1016/S0046-8177(87)80032-1 Pathology of transluminal balloon angioplasty used in the treatment of coronary heart disease
Am. J. Cardiol. Bertrand 63 277 1989 10.1016/0002-9149(89)90330-5 Relation to restenosis after percutaneous transluminal coronary angioplasty to vasomotion of the dilated coronary arterial segment
Hum. Pathol. Gravanis 20 477 1989 10.1016/0046-8177(89)90014-2 Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty
Am. J. Cardiol. Potkin 62 41 1998 10.1016/0002-9149(88)91362-8 Effects of coronary angioplasty on atherosclerotic plaques and relation of plaque composition and arterial size to outcome
Circulation Serruys 77 361 1988 10.1161/01.CIR.77.2.361 Incidence of restenosis after successful coronary angioplasty
Cardiol. Rev. Fleisch 7 215 1999 10.1097/00045415-199907000-00013 Management and outcome of stents in 1998
Prog. Cardiovasc. Dis. Lefkovits 40 141 1997 10.1016/S0033-0620(97)80006-0 Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention
Circulation Liu 79 1374 1989 10.1161/01.CIR.79.6.1374 Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia
Cardiovasc. Pathol. Anderson 1 263 1992 10.1016/1054-8807(92)90037-O Restenosis
Circ. Res. Lafont 76 996 1995 10.1161/01.RES.76.6.996 Restenosis after experimental angioplasty
Cardiovasc. Res. Bauters 31 835 1996 10.1016/S0008-6363(96)00038-7 Mechanisms and prevention of restenosis
Circulation Mintz 94 35 1996 10.1161/01.CIR.94.1.35 Arterial remodeling after coronary angioplasty
Ann. N. Y. Acad. Sci. Mak 811 255 1997 10.1111/j.1749-6632.1997.tb52007.x Clinical trials to prevent restenosis after percutaneous coronary revascularization
Circulation Gallo 97 581 1998 10.1161/01.CIR.97.6.581 Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries
Cardiovasc. Res. Lafont 39 50 1998 10.1016/S0008-6363(98)00109-6 Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials?
Am. J. Cardiol. Di Mario 75 772 1995 10.1016/S0002-9149(99)80409-3 Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy
Circulation Post 96 996 1997 10.1161/01.CIR.96.3.996 Arterial remodeling after balloon angioplasty or stenting in an atherosclerotic experimental model
J. Am. Coll. Cardiol. Chandrasekar 35 555 2000 10.1016/S0735-1097(99)00596-3 Platelets and restenosis
Circulation Ruygrok 94 882 1996 10.1161/01.CIR.94.5.882 Intracoronary stenting. From concept to custom
Circulation Hoffmann 94 1247 1996 10.1161/01.CIR.94.6.1247 Patterns and mechanisms of in-stent restenosis
Circulation Komatsu 98 224 1998 10.1161/01.CIR.98.3.224 Neointimal tissue response at sites of coronary stenting in humans. Macroscopic, histological, and immunohistochemical analyses
Circulation Carrozza 100 756 1999 10.1161/01.CIR.100.7.756 In vivo assessment of stent expansion and recoil in normal porcine coronary arteries. Differential outcome by stent design
Circ. Res. Rogers 84 378 1999 10.1161/01.RES.84.4.378 Balloon-artery interactions during stent placement. A finite element analysis approach to pressure, compliance, and stent design as contributors to vascular injury
N. Engl. J. Med. Kimura 334 561 1996 10.1056/NEJM199602293340903 Three-year follow-up after implantation of metallic coronary-artery stents
10.1016/0735-1097(95)00473-4 Macaya, C.; Serruys, P. W.; Ruygrok, P.; Suryapranata, H.; Mast, G.; Klugmann, S.; Urban, P.; den Heijer, P.; Koch, K.; Simon, R.; Morice, M. C.; Crean, P.; Bonnier, H.; Wijns, W.; Danchin, N.; Bourdonnec, C.; Morel, M. A., for the Benestent Study Group. Continued benefit for coronary stenting compared to balloon angioplasty: one year clinical follow-up of the Benestent trial. J. Am. Coll. Cardiol. 27:255-261; 1996.
Circulation Asakura 97 2003 1998 10.1161/01.CIR.97.20.2003 Remodeling of in-stent neointima, which became thinner and transparent over 3 years. Serial angiographic and angioscopic follow-up
J. Am. Coll. Cardiol. Reimers 30 186 1997 10.1016/S0735-1097(97)00142-3 Long-term clinical follow-up after successful repeat percutaneous intervention for in-stent restenosis
Circulation Bauters 97 318 1998 10.1161/01.CIR.97.4.318 Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis
Pathol. Int. Yutani 49 273 1999 10.1046/j.1440-1827.1999.00861.x Coronary atherosclerosis and interventions
J. Am. Coll. Cardiol. Bertrand 32 562 1998 10.1016/S0735-1097(98)00289-7 Biocompatibility aspects of new stent technology
Thromb. Haemost. Rosanio 82 164 2000 Prevention of restenosis after percutaneous interventions
Circulation Edelman 100 896 1999 10.1161/01.CIR.100.9.896 Stent-versus-stent equivalency trials. Are some stents more equal than others?
Arch. Biochem. Biophys. Ewing 343 131 1997 10.1006/abbi.1997.0169 Reactivity of nitrogen monoxide species with NADH
J. Pharmacol. Exp. Ther. Ewing 283 947 1997 Nitrosylated bovine serum albumin derivatives as pharmacologically active nitric oxide congeners
Trends Biochem. Sci. Mayer 22 477 1997 10.1016/S0968-0004(97)01147-X Biosynthesis and action of nitric oxide in mammalian cells
Curr. Opin. Chem. Biol. Bohle 2 194 1998 10.1016/S1367-5931(98)80060-4 Pathophysiological chemistry of nitric oxide and its oxygenation by-products
Free Radic. Biol. Med. Ewing 25 621 1998 10.1016/S0891-5849(98)00083-5 Specific S-nitrosothiol (thionitrite) quantification as solution nitrite after vanadium(III) reduction and ozone-chemiluminescent detection
Free Radic. Biol. Med. Wink 25 434 1998 10.1016/S0891-5849(98)00092-6 Chemical biology of nitric oxide
Free Radic. Biol. Med. Janero 28 1495 2000 10.1016/S0891-5849(00)00247-1 Nitric oxide (NO)-related pharmaceuticals
Nature Furchgott 288 373 1980 10.1038/288373a0 The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
Trends Pharmacol. Sci. Shulz 15 255 1994 10.1016/0165-6147(94)90321-2 Role of NO in vascular smooth muscle and cardiac muscle function
Curr. Opin. Chem. Biol. Marletta 2 656 1998 10.1016/S1367-5931(98)80098-7 Catalysis by nitric oxide synthase
Arteroscler. Thromb. Tarry 14 938 1994 10.1161/01.ATV.14.6.938 L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty
J. Pharmacol. Exp. Ther. Martin 232 708 1985 Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta
Hypertension Dubey 31 296 1998 10.1161/01.HYP.31.1.296 Cyclic AMP-adenosine pathway induces nitric oxide synthesis in aortic smooth muscle cells
Arterioscler. Thromb. Vasc. Biol. Dimmeler 19 656 1999 10.1161/01.ATV.19.3.656 Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells
Am. J. Physiol. Ma 271 H2045 1996 Exogenous NO inhibits basal NO release from vascular endothelium in vitro and in vivo
J. Vasc. Res. Dusting 32 143 1995 10.1159/000159089 Nitric oxide in cardiovascular disorders
Lancet Petros 338 1557 1991 10.1016/0140-6736(91)92376-D Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock
J. Am. Coll. Cardiol. Williams 27 567 1996 10.1016/0735-1097(95)00522-6 Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
Vasc. Med. Cardillo 3 138 1998 10.1177/1358836X9800300208 Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension
Hypertension Gerhard 27 849 1996 10.1161/01.HYP.27.4.849 Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans
Circ. Res. Cernadas 83 279 1998 10.1161/01.RES.83.3.279 Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats
J. Vasc. Res. Sarkar 35 135 1998 10.1159/000025576 Does nitric oxide regulate smooth muscle cell proliferation?
Proc. Natl. Acad. Sci. USA Radomski 87 5193 1990 10.1073/pnas.87.13.5193 An L-arginine/nitric oxide pathway present in human platelets regulates aggregation
J. Clin. Invest. Zimmerman 98 1699 1996 10.1172/JCI118967 Adhesion and signaling in vascular cell-cell interactions
J. Clin. Invest. Freedman 100 350 1997 10.1172/JCI119540 Nitric oxide released from activated platelets inhibits platelet recruitment
Am. J. Physiol. Armstead 273 H740 1997 Regulation of P-selectin expression in human endothelial cells by nitric oxide
Lancet Celermajer 340 1111 1992 10.1016/0140-6736(92)93147-F Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
Circulation Oemar 97 2494 1998 10.1161/01.CIR.97.25.2494 Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis
J. Cardiovasc. Pharmacol. Freeman 28 345 1996 10.1097/00005344-199609000-00001 Analysis of lysophosphatidylcholine-induced endothelial dysfunction
Circulation Bauersachs 100 292 1999 10.1161/01.CIR.100.3.292 Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression. Role of enhanced vascular superoxide production
Circulation Ito 99 3092 1999 10.1161/01.CIR.99.24.3092 Novel mechanism for endothelial dysfunction. Dysregulation of dimethyl arginine dimethylaminohydrolase
J. Biol. Chem. Liao 270 319 1995 10.1074/jbc.270.1.319 Oxidized low density lipoprotein decreases the expression of endothelial nitric oxide synthase
Circulation John 98 211 1998 10.1161/01.CIR.98.3.211 Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients. A randomized, placebo-controlled, double-blind study
N. Engl. J. Med. DeWood 303 897 1980 10.1056/NEJM198010163031601 Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction
J. Clin. Invest. Freedman 97 979 1996 10.1172/JCI118522 Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis
J. Clin. Invest. Cooke 90 1168 1992 10.1172/JCI115937 Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit
Circulation Lerman 97 2123 1998 10.1161/01.CIR.97.21.2123 Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans
Arterioscler. Thromb. Vasc. Biol. Naruse 14 746 1992 10.1161/01.ATV.14.5.746 Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta
Annu. Rev. Med. Lloyd-Jones 47 365 1996 10.1146/annurev.med.47.1.365 The vascular biology of nitric oxide and its role in atherogenesis
Am. J. Pathol. O’Brien 145 883 1994 Angiogenesis in human coronary atherosclerotic plaques
Surgery Sarkar 118 274 1995 10.1016/S0039-6060(05)80334-4 Nitric oxide inhibition of endothelial cell mitogenesis and proliferation
Circulation Yao 86 1302 1992 10.1161/01.CIR.86.4.1302 Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries
Circ. Res. Niu 74 1133 1994 10.1161/01.RES.74.6.1133 Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils
Circulation Waller 83 I-28 1991 Morphological observations late (greater than 30 days) after clinically successful coronary balloon angioplasty
Circ. Res. Shimokawa 65 740 1989 10.1161/01.RES.65.3.740 Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries
Circulation Van Belle 95 438 1997 10.1161/01.CIR.95.2.438 Stent endothelialization
Eur. J. Pharmacol. Bosmans 310 163 1996 10.1016/0014-2999(96)00377-9 Balloon angioplasty and induction of non-endothelial nitric oxide synthase in rabbit carotid arteries
Circ. Res. Yan 82 21 1998 10.1161/01.RES.82.1.21 Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells
Gen. Pharmacol. Hecker 32 9 1999 10.1016/S0306-3623(98)00082-2 Regulation of inducible nitric oxide synthase gene expression in vascular smooth muscle cells
Eur. J. Pharmacol. Douglas 255 81 1994 10.1016/0014-2999(94)90085-X Functional evidence that balloon angioplasty results in transient nitric oxide synthase induction
Pediatr. Clin. North Am. Nelin 45 531 1998 10.1016/S0031-3955(05)70026-2 The use of inhaled nitric oxide in a wide variety of clinical problems
Circ. Res. Lee 78 337 1996 10.1161/01.RES.78.2.337 Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury
Circulation Adrie 94 1919 1996 10.1161/01.CIR.94.8.1919 Inhaled nitric oxide increases coronary artery patency after thrombolysis
Circ. Res. Kelm 66 1561 1990 10.1161/01.RES.66.6.1561 Control of coronary vascular tone by nitric oxide
Arch. Environ. Health Hugod 34 12 1979 10.1080/00039896.1979.10667360 Ultrastructural changes of the rabbit lung after 5 ppm nitric oxide exposure
Environ. Res. Kagawa 22 485 1982 10.1016/0013-9351(82)90103-7 Respiratory effects of 2-hr exposure to 1.0 ppm nitric oxide in normal subjects
Circ. Res. Girerd 67 1301 1990 10.1161/01.RES.67.6.1301 L-arginine augments endothelium-dependent vasodilation in cholesterol rabbits
Circulation Cooke 83 1057 1991 10.1161/01.CIR.83.3.1057 Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta
J. Clin. Invest. Rossitch 87 1295 1991 10.1172/JCI115132 L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits
Atherosclerosis Boger 136 67 1998 10.1016/S0021-9150(97)00183-4 Dietary L-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits
J. Cardiovasc. Pharmacol. Singer 25 710 1995 10.1097/00005344-199505000-00005 Discordant effects of dietary L-arginine on vascular structure and reactivity in hypercholesterolemic rabbits
Lancet Drexler 338 1546 1991 10.1016/0140-6736(91)92372-9 Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine
Am. J. Cardiol. Dubois-Rande 70 1269 1992 10.1016/0002-9149(92)90760-V Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries
J. Cardiovasc. Pharmacol. Chin-Dusting 28 158 1996 10.1097/00005344-199607000-00023 Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels
J. Clin. Invest. Wang 23 452 1994 Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit
Arterioscler. Thromb. Vasc. Biol. Candipan 16 44 1996 10.1161/01.ATV.16.1.44 Regression or progression. Dependency on vascular nitric oxide
Circulation Boger 96 1282 1997 10.1161/01.CIR.96.4.1282 Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits. Comparison with lovastatin
Circulation Aji 95 430 1997 10.1161/01.CIR.95.2.430 L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL cholesterol receptor knockout mice
Biochem. Biophys. Res. Commun. McNamara 193 291 1993 10.1006/bbrc.1993.1622 L-arginine inhibits balloon catheter-induced intimal hyperplasia
Life Sci. Taguchi 53 387 1993 10.1016/0024-3205(93)90167-2 L-arginine inhibits neointimal formation following balloon injury
Circulation Hamon 90 1357 1994 10.1161/01.CIR.90.3.1357 Long-term administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury
Chin. Med. J. Zhijian 109 592 1996 Long-term oral administration of L-arginine enhances endothelium-dependent vasorelaxation and inhibits neointimal thickening after endothelial denudation in rats
Arterioscler. Thromb. Vasc. Biol. Bosmans 19 767 1999 10.1161/01.ATV.19.3.767 Continuous perivascular L-arginine delivery increases total vessel area and reduces neointimal thickening after experimental balloon dilatation
J. Am. Coll. Cardiol. Wang 28 1573 1996 10.1016/S0735-1097(96)00337-3 Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits
J. Am. Coll. Cardiol. Le Tourneau 33 876 1999 10.1016/S0735-1097(98)00621-4 Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit
Circulation Schwarzacher 95 1863 1997 10.1161/01.CIR.95.7.1863 Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty
Circulation Niebauer 100 1830 1999 10.1161/01.CIR.100.17.1830 Local L-arginine delivery after balloon angioplasty reduced monocyte binding and induces apoptosis
Cardiovasc. Res. Greenlees 35 351 1997 10.1016/S0008-6363(97)00122-3 The effects of L-arginine on neointimal formation and vascular function following balloon injury in heritable hyperlipidemic rabbits
N. Engl. J. Med. Adelman 329 221 1993 10.1056/NEJM199307223290401 A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group
J. Clin. Invest. Giugliano 99 433 1997 10.1172/JCI119177 The vascular effects of L-arginine in humans
Circulation Cardillo 100 820 1999 10.1161/01.CIR.100.8.820 Insulin stimulates both endothelium and nitric oxide activity in the human forearm
J. Clin. Invest. Ohara 91 2546 1993 10.1172/JCI116491 Hypercholesterolemia increases endothelial superoxide anion production
Biochemistry Sennequier 35 5883 1996 10.1021/bi952844e Analysis of substrate-induced electronic, catalytic, and structural changes in inducible NO synthase
Circ. Res. Durante 78 1075 1996 10.1161/01.RES.78.6.1075 Differential regulation of L-arginine transport and nitric oxide production by vascular smooth muscle and endothelium
J. Am. Coll. Cardiol. Quyyumi 32 904 1998 10.1016/S0735-1097(98)00323-4 Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine
Hypertension Hattori 33 943 1999 10.1161/01.HYP.33.4.943 Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells
FEBS Lett. Hishikawa 360 291 1995 10.1016/0014-5793(95)00124-R Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells
J. Clin. Invest. DiMinno 75 328 1985 10.1172/JCI111705 Functionally thrombasthenic state in normal platelets following administration of ticlopidine
Hypertension Frolich 13 I-1125 1989 Angiotesin converting enzyme inhibitors
Allergol. Immunopathol. Garcia 18 53 1990 New approach to the mechanism of antiasthmatic action of tranilast
J. Cardiovasc. Pharmacol. Hishikawa 28 200 1996 10.1097/00005344-199608000-00004 Tranilast restores cytokine-induced nitric oxide production against platelet-derived growth factor in vascular smooth muscle cells
Eur. J. Pharmacol. Ikeda 314 197 1996 10.1016/S0014-2999(96)00551-1 Effect of cilostazol, a cAMP phosphodiesterase inhibitor, on nitric oxide production by vascular smooth muscle cells
Br. J. Pharmacol. Hecker 120 1067 1997 10.1038/sj.bjp.0701026 Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells
Circulation Ikeda 99 1230 1999 10.1161/01.CIR.99.9.1230 Homocysteine increases nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells
Cardiovasc. Res. Ikeda 35 168 1997 10.1016/S0008-6363(97)00068-0 Adenosine stimulates nitric oxide synthesis in vascular smooth muscle cells
Hypertension Inoue 25 711 1995 10.1161/01.HYP.25.4.711 cGMP upregulates nitric oxide synthase expression in vascular smooth muscle cells
Hypertension Oparil 33 II-170 1999 10.1161/01.HYP.33.1.170 Hormones and vasoprotection
J. Clin. Invest. Law 98 1897 1996 10.1172/JCI118991 Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia
J. Vasc. Surg. Foegh 19 722 1994 10.1016/S0741-5214(94)70047-8 Estradiol inhibition of arterial neointimal hyperplasia after balloon injury
Circulation Levine 94 2221 1996 10.1161/01.CIR.94.9.2221 Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery
J. Clin. Invest. Sullivan 96 2482 1995 10.1172/JCI118307 Estrogen inhibits the response-to-injury in a mouse carotid artery model
J. Am. Coll. Cardiol. Geary 31 1158 1998 10.1016/S0735-1097(98)00042-4 Conjugated equine estrogens inhibit progression of atherosclerosis but have no effect on intimal hyperplasia or arterial remodeling induced by balloon catheter injury in monkeys
Circulation Holm 100 1727 1999 10.1161/01.CIR.100.16.1727 The direct antiatherogenic effect of estrogen is present, absent, or reversed, depending on the state of the arterial endothelium. A time course study in cholesterol-clamped rabbits
J. Cardiovasc. Pharmacol. De Lorgeril 32 225 1998 10.1097/00005344-199808000-00009 Ticlopidine increases nitric oxide generation in heart-transplant recipients
Bertrand, M. E.; Allain, H.; LaBlanche, J. M., on behalf of the investigators of the TACT study. Results of a randomized trial of ticlopidine versus placebo for the prevention of acute closure and restenosis after coronary angioplasty (PTCA): the TACT study. Circulation 82:III-190 (abstr.); 1990.
White, C. W.; Knudson, M.; Schmidt, D.; Chisholm, R. J.; Vandormael, M.; Morton, B.; Roy, L.; Khaja, F.; Reitman, M., and the Ticlopidine Study Group. Neither ticlopidine or aspirin-dipyridamole prevents restenosis post-PTCA: results from a randomized placebo-controlled multicenter trial. Circulation 76:IV-213 (abstr.); 1997.
Kitazume, H.; Kubo, I.; Iwama, T.; Ageishi, Y.; Suzuki, A. Combined use of aspirin, ticlopidine and nicorandil prevented restenosis after coronary angioplasty. Circulation 78:II-633 (abstr.); 1998.
Science Powell 245 186 1989 10.1126/science.2526370 Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury
Jpn. Circ. J. Miyauchi 62 53 1998 10.1253/jcj.62.53 Limitations of angiotensin-converting enzyme inhibitor in restenosis of a deep arterial injury model
Circulation 86 100 1994 Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study
J. Am. Coll. Cardiol. Faxon 25 362 1995 10.1016/0735-1097(94)00368-Z Effect of high dose angiotensin-converting enzyme inhibition on restenosis
Circulation Desmet 89 385 1994 10.1161/01.CIR.89.1.385 Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty
Clin. Cardiol. Gibbons 20 II-18 1997 10.1002/j.1932-8737.1997.tb00008.x Vasculoprotective and cardioprotective mechanisms of angiotensin-converting enzyme inhibition
Hypertension Hanson 18 II-70 1991 10.1161/01.HYP.18.4_Suppl.II70 Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in baboon
J. Cardiovasc. Pharmacol. Miyazawa 30 157 1997 10.1097/00005344-199708000-00002 Effects of pemirolast and tranilast on intimal thickening after arterial injury in the rat
Eur. J. Pharmacol. Fukuyama 318 327 1996 10.1016/S0014-2999(96)00774-1 Tranilast suppresses the vascular intimal hyperplasia after balloon injury in rabbits fed on a high-cholesterol diet
Udea, K.; Tamai, H.; Hsu, Y.-S. Efficacy of tranilast on restenosis after percutaneous transluminal coronary angioplasty in small sized coronary arteries. Circulation 92:I-346; 1995.
10.1016/0735-1097(95)92396-M Udea, K.; Tamai, H.; Hsu, Y.-S.; Ono, S.; Tanaka, S.; Kosuga, K.; Okada, M.; Wan, M.; Motohara, S.; Uehata, H. Efficacy of tranilast on restenosis after coronary angioplasty: is there any rebound phenomenon after ceasing tranilast at 3 months? J. Am. Coll. Cardiol. 25:225A (abstr.); 1995.
Udea, K.; Tamai, H.; Kyo, E. Efficacy of tranilast on restenosis after PTCA. Jpn. J. Interventional Cardiol. 8:104 (abstr.); 1993.
Am. Heart J. Kosuga 134 712 1997 10.1016/S0002-8703(97)70055-3 Effectiveness of tranilast on restenosis after directional coronary athrectomy
Am. Heart. J. Holmes 139 23 2000 10.1016/S0002-8703(00)90304-1 The PRESTO (prevention of restenosis with tranilast and its outcomes) protocol
Jpn. Circ. J. Tsutsui 60 207 1996 10.1253/jcj.60.207 Effect of cilostazol, a novel anti-platelet drug, on restenosis after percutaneous transluminal coronary angioplasty
Atherosclerosis Ishizaka 142 41 1999 10.1016/S0021-9150(98)00147-6 Effects of a single local administration of cilostazol on neointimal formation in balloon-injured rat carotid artery
Am. J. Cardiol. Take 79 1097 1997 10.1016/S0002-9149(97)00052-0 Effect of cilostazol in preventing restenosis after percutaneous transluminal coronary angioplasty
Circulation Tsuchikane 100 21 1999 10.1161/01.CIR.100.1.21 Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty
Am. Heart J. Tsuchikane 135 495 1998 10.1016/S0002-8703(98)70327-8 Impact of cilostazol on intimal proliferation after directional coronary atherectomy
Clin. Ther. Kunishima 19 1058 1997 10.1016/S0149-2918(97)80058-6 A randomized trial of aspirin versus cilostazol therapy after successful coronary stent implantation
Am. J. Cardiol. Sekiya 82 144 1998 10.1016/S0002-9149(98)00323-3 Effects of probucol and cilostazol alone or in combination on frequency of poststenting restenosis
Cathet. Cardiovasc. Diagn. Yamasaki 44 387 1998 10.1002/(SICI)1097-0304(199808)44:4<387::AID-CCD4>3.0.CO;2-0 Effects of cilostazol on late lumen loss after Palmaz-Schatz stent implantation
J. Vasc. Res. Busse 35 73 1998 10.1159/000025568 Pulsatile stretch and shear stress
Arterioscler. Thromb. Vasc. Biol. Lewis 19 2782 1999 10.1161/01.ATV.19.11.2782 Exercise training increases basal nitric oxide production from the forearm in hypercholesterolemic patients
Life Sci. Posch 64 663 1999 10.1016/S0024-3205(98)00608-0 Selective stimulation of L-arginine uptake contributes to shear stress-induced formation of nitric oxide
Jpn. Circ. J. Kubo 56 413 1992 10.1253/jcj.56.413 Preventive effect of exercise training on recurrent stenosis after percutaneous transluminal coronary angioplasty (PTCA)
Nature Med. Williams 3 273 1997 10.1038/nm0397-273 Estrogens, progestins and coronary artery reactivity
Eur. J. Pharmacol. Nishio 374 127 1999 10.1016/S0014-2999(99)00271-X Troglitazone inhibits alpha-1-adrenoreceptor-induced DNA synthesis in vascular smooth muscle cells
Am. J. Respir. Cell. Mol. Biol. Haddad 16 501 1997 10.1165/ajrcmb.16.5.9160832 Modulation of adenovirus-mediated gene transfer by nitric oxide
Curr. Opin. Nephrol. Hypertens. Kibbe 8 75 1999 10.1097/00041552-199901000-00012 Nitric oxide synthase gene transfer to the vessel wall
Molec. Med. Tzeng 2 211 1996 10.1007/BF03401618 Vascular gene transfer of the human inducible nitric oxide synthase
Cardiovasc. Res. Cable 35 553 1997 10.1016/S0008-6363(97)00161-2 Expression and function of a recombinant endothelial nitric oxide synthase gene in porcine coronary arteries
Circulation Cable 96 II-173 1997 Recombinant endothelial nitric oxide synthase-transduced human saphenous veins. Gene therapy to augment nitric oxide production in bypass conduits
J. Am. Coll. Surg. Shears 187 295 1998 10.1016/S1072-7515(98)00163-X Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo
Proc. Nat. Acad. Sci. USA Von Der Leyen 92 1137 1995 10.1073/pnas.92.4.1137 Gene therapy inhibiting neointimal vascular lesion
Circulation Janssens 97 1274 1998 10.1161/01.CIR.97.13.1274 Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats
Circulation Varenne 98 919 1998 10.1161/01.CIR.98.9.919 Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs
J. Clin. Invest. Newman 96 2955 1995 10.1172/JCI118367 Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia
Circulation Zhou 100 1569 1999 10.1161/01.CIR.100.14.1569 Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall
Circ. Res. Chen 82 862 1998 10.1161/01.RES.82.8.862 Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery
Circ. Res. Baek 82 295 1998 10.1161/01.RES.82.3.295 Gene therapy for restenosis. Getting nearer the heart of the matter
Circ. Res. De Young 82 306 1998 10.1161/01.RES.82.3.306 Gene therapy for restenosis. Are we ready?
Circ. Res. Libby 82 404 1998 10.1161/01.RES.82.3.404 Gene therapy of restenosis. Promise and perils
Science Rosenberg 287 1751 2000 10.1126/science.287.5459.1751 Gene therapist, heal thyself
Circulation Rosengart 100 468 1999 10.1161/01.CIR.100.5.468 Angiogenesis gene therapy. Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
Naun-Schmied. Arch. Pharmacol. Feelisch 358 113 1998 10.1007/PL00005231 The use of nitric oxide donors in pharmacological studies
J. Am. Coll. Cardiol. Anderson 24 555 1994 10.1016/0735-1097(94)90316-6 Nitric oxide and nitrovasodilators
Circ. Res. Mohazzab-H 84 220 1999 10.1161/01.RES.84.2.220 Potential role of a membrane-bound NADH oxidoreductase in nitric oxide release and arterial relaxation to nitroprusside
Circulation Weidinger 84 755 1991 10.1161/01.CIR.84.2.755 Hypercholesterolemia enhances macrophage recruitment and dysfunction of regenerated endothelium after balloon injury of the rabbit iliac artery
Atherosclerosis Kariya 80 143 1989 10.1016/0021-9150(89)90022-1 Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells
J. Vasc. Surg. Wolf 21 499 1995 10.1016/S0741-5214(95)70293-8 Nitroglycerine decreases medial smooth muscle cell proliferation after arterial balloon injury
Atherosclerosis Seki 117 97 1995 10.1016/0021-9150(95)05563-C FK409, a new nitric-oxide donor, suppressed smooth muscle proliferation in the rat model of balloon angioplasty
Meth. Enzymol. Keefer 268 281 1996 10.1016/S0076-6879(96)68030-6 “NONOates” (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors
Clin. Exp. Pharmacol. Physiol. Yin 24 436 1997 10.1111/j.1440-1681.1997.tb01218.x A nitric oxide donor (spermine-NONOATE) prevents the formation of neointima in rabbit carotid artery
J. Am. Coll. Cardiol. Kaul 35 493 2000 10.1016/S0735-1097(99)00543-4 Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury
Coron. Artery Dis. Buergler 11 351 2000 10.1097/00019501-200006000-00009 Use of nitric-oxide-eluting polymer-coated coronary stents for prevention of restenosis in pigs
Am. J. Physiol. Siegfried 263 H771 1992 Beneficial effects of SPM-5185, a cysteine-containing NO donor, in myocardial ischemia-reperfusion
J. Cardiovasc. Pharmacol. De Meyer 26 272 1995 10.1097/00005344-199508000-00013 Effect of nitric oxide donors on neointima formation and vascular reactivity in the collared carotid artery of rabbits
Am. J. Physiol. Guo 269 H1122 1995 Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury
Free Radic. Biol. Med. Jourd’Heuil 28 409 2000 10.1016/S0891-5849(99)00257-9 Dynamic state of S-nitrosothiols in human plasma and whole blood
J. Clin. Invest. Marks 96 2630 1995 10.1172/JCI118328 Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide
J. Am. Coll. Cardiol. Maalej 33 1408 1999 10.1016/S0735-1097(98)00687-1 The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces
Lancet Langford 344 1458 1994 10.1016/S0140-6736(94)90287-9 Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty
J. Cardiovasc. Pharmacol. Feelisch 14 S13 1989 10.1097/00005344-198914110-00004 On the mechanism of NO release from sydnonimines
Cardiovasc. Res. Groves 30 87 1995 10.1016/0008-6363(95)00009-7 The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty
Circulation LaBlanche 95 83 1997 10.1161/01.CIR.95.1.83 Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD study
J. Cardiovasc. Pharmacol. Thaulow 33 S12 1999 10.1097/00005344-199900002-00004 Pharmacologic effects of calcium channel blockers on restenosis
Am. J. Physiol. Davidson 17 L437 1997 NO elicits prolonged relaxation of bovine pulmonary arteries via endogenous peroxynitrite generation
Nature Ernst 385 480 1997 10.1038/385480c0 Alternative therapy bias
Circulation Bilder 99 3292 1999 10.1161/01.CIR.99.25.3292 Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR10511A
Antisense Nucleic Acid Drug Dev. Lee 9 487 1999 10.1089/oli.1.1999.9.487 Antisense strategies to inhibit restenosis
Grube, E.; Gerkens, U.; Oesterle, S.; Pomerantsev, E.; Pomerantseva, I.; Froix, M.; Eury, R.; Yeung, A.; Stertzer, S. Inhibition of in-stent restenosis by the Quanam drug delivery polymer stent, in humans followed for up to eight months. J. Am. Coll. Cardiol. 35:A34 (abstr.); 2000.
Circ. Res. Sun 85 288 1999 10.1161/01.RES.85.3.288 Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice
Hum. Gene Ther. Laitinen 8 1737 1997 10.1089/hum.1997.8.15-1737 VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries
Nat. Med. Tsurmi 3 879 1997 10.1038/nm0897-879 Reciprocal relation between VEGF and NO in the regulation of endothelial integrity
Am. J. Physiol. Sharma 276 H1450 1999 NOS gene transfer inhibits expression of cell cycle regulatory molecules in vascular smooth muscle cells
Gastroenterology Fiorucci 118 404 2000 10.1016/S0016-5085(00)70223-X NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines
Circulation Tanner 101 1982 2000 10.1161/01.CIR.101.16.1982 Nitric oxide modulates expression of cell cycle regulatory proteins. Cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation
Clin. Exp. Pharmacol. Physiol. Lee 26 1013 1999 10.1046/j.1440-1681.1999.03183.x Role of inducible nitric oxide synthase in transplant atherosclerosis
Circulation Dorros 98 642 1998 10.1161/01.CIR.98.7.642 Four year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis
10.1161/01.CIR.100.3.236 Buller, C. T.; Dzavik, V.; Carere, R. G.; Mancini, J.; Barbeau, G.; Lazzam, C.; Anderson, T. J.; Knudtson, M. L.; Marquis, J.-F.; Suzuki, T.; Cohen, E. A.; Fox, R. S.; Teo, K. K., for the TOSCA investigators. Stenting versus balloon angioplasty in occluded coronary arteries. The total occlusion study of Canada (TOSCA). Circulation 100:236-242; 1999.
Int. J. Exp. Pathol. Ferns 81 63 2000 10.1046/j.1365-2613.2000.00143.x The mechanisms of coronary restenosis
J. Vasc. Interv. Radiol. Narayanaswamy 11 5 2000 10.1016/S1051-0443(07)61271-8 Animal models for atherosclerosis, restenosis, and endovascular graft research
Cardiovasc. Res. Pasterkamp 45 843 2000 10.1016/S0008-6363(99)00377-6 Arterial remodeling in atherosclerosis, restenosis and after alteration of blood flow
Circulation Ward 102 1186 2000 10.1161/01.CIR.102.10.1186 Arterial remodeling. Mechanisms and clinical implications
Front. Biosci. Petkova 5 D452 2000 10.2741/Petkova Cell cycle molecules and diseases of the cardiovascular system
Histol. Histopathol. Rivard 15 557 2000 Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases
Trends Pharmacol. Sci. Bult 21 274 2000 10.1016/S0165-6147(00)01505-4 Restenosis
Circulation Kuntz 101 2130 2000 10.1161/01.CIR.101.18.2130 Prevention of coronary restenosis
Circulation Raizner 102 951 2000 10.1161/01.CIR.102.9.951 Inhibition of restenosis with β-emitting radiotherapy. Report of the proliferation reduction with vascular energy trial (PREVENT)
Circulation Thorin 101 1430 2000 10.1161/01.CIR.101.12.1430 Influence of postangioplasty beta-irradiation on endothelial function in porcine coronary arteries
Circulation Loscalzo 101 2126 2000 10.1161/01.CIR.101.18.2126 What we know and don’t know about L-arginine and NO
Scand. Cardiovasc. J. Holm 34 28 2000 10.1080/14017430050142369 Effects of L-arginine on vascular smooth muscle cell proliferation and apoptosis after balloon injury
Hypertension Garg 36 430 2000 10.1161/01.HYP.36.3.430 Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilation in obese subjects
Circulation Virdis 101 2258 2000 10.1161/01.CIR.101.19.2258 Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women
Circulation Stefano 101 1594 2000 10.1161/01.CIR.101.13.1594 Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia
Hypertension Agata 36 364 2000 10.1161/01.HYP.36.3.364 Bradykinin B1 receptor mediates inhibition of neointima formation in rat artery after balloon angioplasty
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.